CREOSALUS INC.
Louisville, KY · Medtech · Private
Porous Brain Infusion Catheter (PBIC) for convection-enhanced delivery of therapeutics into the central nervous system
creosalus.com →- Grants
- $7.5M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $10K
- 1 award · Health and Human S
- #630 of 4531 in medtech
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Creosalus - Tetras Service Warranty And Maintenance Agreement (last 10 Months Of FY'14; Dec. 4, 2013 - Oct. 3, 2014 Covers One Pm Visit, Travel Due To Equipment Failure, Parts, Laber, Time, Software Updates, Technical Support) | $9,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Catheter for Large Volume Intraparenchymal Brain Therapies | $1,493,724 | |
| Federal grant | Department of Health and Human Services · Phase II · Catheter for Large Volume Intraparenchymal Brain Therapies | $2,992,280 | |
| Federal grant | Department of Health and Human Services · Phase II · Catheter for Large Volume Intraparenchymal Brain Therapies | $1,193,695 | |
| Federal grant | Department of Health and Human Services · Phase II · Catheter for Large Volume Intraparenchymal Brain Therapies | $304,861 | |
| Federal grant | Department of Health and Human Services · Phase II · Comparison of convection enhanced delivery systems in a randomized controlled clinical study of recurrent Grade 3-4 glioma patients | $857,315 | |
| Federal grant | Department of Health and Human Services · Phase II · Comparison of convection enhanced delivery systems in a randomized controlled clinical study of recurrent Grade 3-4 glioma patients | $682,122 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 627 | PROPRIA LLC | $11K | $574K |
| 628 | DuraStat LLC | $11K | $6.8M |
| 629 | Stimlabs LLC | $10K | $10M |
| 630 | CREOSALUS INC. | $10K | — |
| 631 | ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC | $10K | — |
| 632 | InCellDx, Inc. | $10K | $9.5M |
| 633 | Insightra Medical, Inc. | $9K | $20M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Reaction Cell For Asyncronous Multiple Peptide Instrumentapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.